ECTS Philippe Bordier Award
Nominations period: nominations are now closed.
Doctor Philippe Bordier (1927-1977) contributed significantly to the bone field by developing bone histomorphometry, which he applied to the analysis of several bone diseases. His work and dynamism in science has been recognised in Europe and United States.
The award is for €1000 (Euros) and is announced during the ECTS annual congress.
Eligibility
The ECTS Philippe Bordier Clinical Award is open to individuals who have made a significant clinical contribution to the field of bone and calcified tissue.
ECTS Board members are not eligible to this award during term of office in the ECTS Board.
Submission Procedure
The Call for Nominations for the 2023 Philippe Bordier Award are now closed.
Nominees must be nominated and seconded by ECTS members, via the online form.
Review Procedure
All nominations are reviewed by an independent panel of reviewers. The final decision is based on the marks and comments from the reviewers and any conflicts of interest are identified and dealt with appropriately.
Winner of the 2023 Bordier Award
Congratulations to Prof M. Carola Zillikens, Bone Center, Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Netherlands, recipient of the 2023 Philippe Bordier Award presented during the ECTS 2023 Congress in Liverpool.
For a full list of previous Award recipients, please visit the Previous Grants section.
Professor Carola Zillikens is well-known within the ECTS community and an excellent clinical and translational researcher and lecturer in the bone field. For all these reasons, she greatly deserves to receive this award.
She founded and heads the Erasmus MC Bone Center, a multidisciplinary expertise center for patients with complex or rare calcium and bone disorders. She is past President of the Dutch Bone Society (NVCB). From 2015 to 2021 she was Board Member of the ECTS and chaired the ECTS Clinical Science Committee, coordinating several review papers and position statements e.g., on denosumab discontinuation, hypophosphatasia, tumor induced osteomalacia, bone health after organ transplantation, after bariatric surgery and with cancer treatment, premenopausal osteoporosis, osteonecrosis of the jaw and medical management of atypical femur fractures (AFFs). She heads the Bone Network of the Dutch Society for Endocrinology (NVE). She is a member of the Steering Committee of the European Reference Network (ERN) for rare bone disorders (BOND) and member of the ASBMR Professional Practice Committee. She coordinates a Dutch registry on chronic hypophosphatemia and is member of the International XLH registry.
Her research topics include the (genetic) background of calcium and bone disorders including AFFs, aiming for personalised treatment and she studies the role of novel risk factors for fractures such as mild hyponatremia, high-normal serum levels of phosphate and Advanced Glycation End-products (AGEs). She has co-authored over 280 papers. One of her top publications wasa shared first authorship in the N Engl J Med in 2013 on mutations in PLS3 causing X-linked osteoporosis.
Congratulations Carola on this well-deserved award!
